瘰疬宁治疗淋巴结核临床研究  

Clinical Research of Lymphatic Treated by Scrofula Ning

作　　者：钮晓红[1] 黄子慧[1] 杨春睿[1] 

机构地区：[1]南京中医药大学附属南京市中西医结合医院,江苏南京210014

出　　处：《中医学报》2014年第3期399-401,共3页Acta Chinese Medicine

基　　金：国家中医药管理局科学技术研究专项(编号:04-05LP26);南京市医学科技发展重大项目(编号:12)

摘　　要：目的:观察瘰疬宁治疗淋巴结核的临床疗效。方法:将260例患者按随机、双盲、平行对照的方法分为对照组和试验组,每组各130例。对照组采用抗结核西药三联(安慰剂+异烟肼+利福平+乙胺丁醇)治疗;试验组在对照组治疗基础上加用瘰疬宁治疗。两组均治疗6个月后观察疗效及安全性指标。结果:治疗后试验组有效率为96.15%,对照组有效率为76.15%。两组疗效比较,差异有统计学意义,治疗组优于对照组(P≤0.01),其中以肝郁痰凝证疗效最佳(P≤0.01);治疗后两组ALT、AST比较,差异无统计学意义(P>0.05)。结论:瘰疬宁是一种治疗淋巴结核有效、安全的治疗药物。Objective：To investigate the clinical efficacy of Scrofula Ning treatment of scrofula. Methods ：260 patients randomized,double-blind,parallel-group approach divided into control and experimental groups ,each group 130 cases. The control group with triple anti- TB medicine（ placebo ＋ rifampicin ＋ isoniazid ＋ ethambutol） treatment;trial group were treated based on treatment with scrofula Ning. Both groups were observed after 6 months of treatment efficacy and safety indicators. Results lAfter treatment,the test group was 96. 15% ,the control group was 76.15%. Comparison of two groups, the difference was statistically significant, the treatment group than the control group（P~〈0.01 ） ,which permits liver Tanning best effect （P ~〈0.01 ） ;groups after treatment ALT, AST, the difference was no statistically significant（ P 〉 0.05 ）. Conclusion：scrofula Ning is a therapeutic lymphatic effective and safe therapy.

关 键 词：淋巴结核 瘰疬宁 异烟肼 利福平 乙胺丁醇 

分 类 号：R259.22[医药卫生—中西医结合]